GROUP ONE TRADING, L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B903. A total of 4 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$2,000
-66.7%
5,400
-57.5%
0.00%
Q2 2018$6,000
-64.7%
12,700
+74.0%
0.00%
Q1 2018$17,000
-93.6%
7,300
-92.2%
0.00%
-100.0%
Q4 2017$266,000
+15.7%
93,800
+16.5%
0.00%0.0%
Q3 2017$230,000
+1.8%
80,500
-11.8%
0.00%0.0%
Q2 2017$226,000
-71.9%
91,300
-59.1%
0.00%
-77.8%
Q1 2017$805,000
+113.0%
223,100
+108.9%
0.01%
+125.0%
Q4 2016$378,000
-40.3%
106,800
-31.8%
0.00%
-42.9%
Q3 2016$633,000
+42.2%
156,600
+54.4%
0.01%
+40.0%
Q2 2016$445,000
-65.3%
101,400
-70.2%
0.01%
-72.2%
Q1 2016$1,284,000
-61.0%
339,800
+61.7%
0.02%
-53.8%
Q4 2015$3,296,000
+53.8%
210,200
+3.4%
0.04%
+30.0%
Q3 2015$2,143,000
-60.1%
203,300
-4.5%
0.03%
-60.0%
Q2 2015$5,367,000
-21.6%
212,800
-13.4%
0.08%
-30.6%
Q1 2015$6,850,000
+92.9%
245,800
+26.3%
0.11%
+100.0%
Q4 2014$3,551,000
+14.3%
194,600
-18.8%
0.05%
+12.5%
Q3 2014$3,107,000
+111.4%
239,700
+166.0%
0.05%
+108.7%
Q2 2014$1,470,000
-27.7%
90,100
-21.7%
0.02%
-32.4%
Q1 2014$2,032,000
-56.8%
115,000
-40.8%
0.03%
-52.1%
Q4 2013$4,699,000
-39.8%
194,100
-11.9%
0.07%
-52.3%
Q3 2013$7,805,000
+569.4%
220,300
+194.9%
0.15%
+413.8%
Q2 2013$1,166,00074,7000.03%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 194,600$3,551,0000.05%
SIMPLEX TRADING, LLC 333$93,0000.01%
Marathon Trading Investment Management LLC 25,000$456,0000.01%
Citadel Advisors 131,100$2,393,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders